UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity

Clinical immunology (Orlando, Fla.), 2013-12, Vol.149 (3), p.556-565

2013

Link zum Volltext

Verfügbarkeit prüfen

The Pathophysiologic Role of Monocytes and Macrophages in Systemic Lupus Erythematosus: A Reappraisal

Seminars in arthritis and rheumatism, 2010-06, Vol.39 (6), p.491-503

2010

Link zum Volltext

Verfügbarkeit prüfen

New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab

Seminars in arthritis and rheumatism, 2017-06, Vol.46 (6), p.788-790

2017

Link zum Volltext

Verfügbarkeit prüfen

The abnormal signaling of the B cell receptor and co-receptors of lupus B cells

Clinical immunology (Orlando, Fla.), 2024-06, Vol.263, p.110222-110222, Article 110222

Liossis, Stamatis-Nick C.

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Arthritis research & therapy, 2020-03, Vol.22 (1), p.56-8, Article 56

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Systemic Sclerosis-Associated Calcinosis: A Case Report of Rituximab-Induced Regression of CREST-Related Calcinosis and Review of the Literature

Seminars in arthritis and rheumatism, 2012-06, Vol.41 (6), p.822-829

2012

Link zum Volltext

Verfügbarkeit prüfen

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

Expert opinion on investigational drugs, 2008-03, Vol.17 (3), p.349-359

2008

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature

Rheumatology and therapy., 2020-12, Vol.7 (4), p.1045-1052

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments

Expert opinion on pharmacotherapy, 2014-04, Vol.15 (6), p.833-840

2014

Link zum Volltext

Verfügbarkeit prüfen

Th1/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosus

Clinical immunology (Orlando, Fla.), 2018-10, Vol.195, p.101-106

2018

Link zum Volltext

Verfügbarkeit prüfen

B cell depletion treatment decreases Th17 cells in patients with rheumatoid arthritis

Clinical immunology (Orlando, Fla.), 2021-12, Vol.233, p.108877-108877, Article 108877

2021

Link zum Volltext

Verfügbarkeit prüfen

Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis

Seminars in arthritis and rheumatism, 2010-04, Vol.39 (5), p.369-383

2010

Link zum Volltext

Verfügbarkeit prüfen

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Rheumatology (Oxford, England), 2010-02, Vol.49 (2), p.271-280

2010

Link zum Volltext

Verfügbarkeit prüfen

Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

Annals of the rheumatic diseases, 2007-06, Vol.66 (6), p.842-843

2007

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of human systemic lupus erythematosus: recent advances

Trends in molecular medicine, 2010-02, Vol.16 (2), p.47-57

2010

Link zum Volltext

Verfügbarkeit prüfen

Acute posterior multifocal placoid pigment epitheliopathy in a patient with familial Mediterranean fever

Clinical and experimental optometry, 2016-07, Vol.99 (4), p.385-387

2016

Link zum Volltext

Verfügbarkeit prüfen

The Role of B Cells in Scleroderma Lung Disease Pathogenesis

Frontiers in medicine, 2022-07, Vol.9, p.936182-936182

2022

Link zum Volltext

Verfügbarkeit prüfen

B Cell-Based Treatments in SLE: Past Experience and Current Directions

Current rheumatology reports, 2017-11, Vol.19 (12), p.78-78, Article 78

2017

Link zum Volltext

Verfügbarkeit prüfen

Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature

Seminars in arthritis and rheumatism, 2010-10, Vol.40 (2), p.127-136

2010

Link zum Volltext

Verfügbarkeit prüfen

Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells

Clinical immunology (Orlando, Fla.), 2008-06, Vol.127 (3), p.280-285

2008

Link zum Volltext

Verfügbarkeit prüfen

B cells tell scleroderma fibroblasts to produce collagen

Arthritis research & therapy, 2013-01, Vol.15 (6), p.125-125

2013

Link zum Volltext

Verfügbarkeit prüfen

Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion

Frontiers in medicine, 2022-06, Vol.9, p.937561-937561

2022

Link zum Volltext

Verfügbarkeit prüfen

B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis

Rheumatology international, 2019-11, Vol.39 (11), p.1889-1898

2019

Link zum Volltext

Verfügbarkeit prüfen

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

International Journal of Rheumatology, 2011-01, Vol.2011, p.214013-7

2011

Link zum Volltext

Verfügbarkeit prüfen

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin

Arthritis research & therapy, 2012-06, Vol.14 (3), p.R145-R145

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(48)
Science & Technology
(45)
Life Sciences & Biomedicine
(42)
Rheumatology
(22)
Animals
(19)
Female
(19)
Lupus Erythematosus, Systemic - Immunology
(19)
Immunology
(17)
Male
(17)
Adult
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Middle Aged
(15)
Systemic Lupus Erythematosus
(15)
Aged
(12)
B Cells
(9)
B-Lymphocytes - Immunology
(9)
Rituximab
(9)
Signal Transduction
(9)
Scleroderma
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity

The Pathophysiologic Role of Monocytes and Macrophages in Systemic Lupus Erythematosus: A Reappraisal

New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab

The abnormal signaling of the B cell receptor and co-receptors of lupus B cells

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

Treatment of Systemic Sclerosis-Associated Calcinosis: A Case Report of Rituximab-Induced Regression of CREST-Related Calcinosis and Review of the Literature

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis

Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature

Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments

Th1/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosus

B cell depletion treatment decreases Th17 cells in patients with rheumatoid arthritis

Wnt Pathway and IL-17: Novel Regulators of Joint Remodeling in Rheumatic Diseases. Looking Beyond the RANK-RANKL-OPG Axis

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

Pathogenesis of human systemic lupus erythematosus: recent advances

Acute posterior multifocal placoid pigment epitheliopathy in a patient with familial Mediterranean fever

The Role of B Cells in Scleroderma Lung Disease Pathogenesis

B Cell-Based Treatments in SLE: Past Experience and Current Directions

Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature

Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells

B cells tell scleroderma fibroblasts to produce collagen

Treating Autoimmune-Related Interstitial Lung Disease With B Cell Depletion

B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis

B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence

B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin

Suchergebnisse filtern